XPHY.CN
Xphyto Therapeutics Corp
Price:  
0.50 
CAD
Volume:  
16,960.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XPHY.CN EV/EBITDA

-163.8%
Upside

As of 2025-09-18, the EV/EBITDA ratio of Xphyto Therapeutics Corp (XPHY.CN) is -9.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XPHY.CN's latest enterprise value is 54.15 mil CAD. XPHY.CN's TTM EBITDA according to its financial statements is -5.82 mil CAD. Dividing these 2 quantities gives us the above XPHY.CN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.0x - 4.7x 3.8x
Forward P/E multiples 4.1x - 7.1x 5.6x
Fair Price (0.28) - (0.32) (0.32)
Upside -156.5% - -163.7% -163.8%
0.50 CAD
Stock Price
(0.32) CAD
Fair Price

XPHY.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA